Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Comera Life Sciences Holdings Inc CMRA

Healthcare Biotechnology
Comera Life Sciences Holdings, Inc. is a pre-clinical biotechnology company. The Company applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The Company is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary... see more

Recent & Breaking News (OTCQB:CMRA)

Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

GlobeNewswire January 4, 2024

Comera Life Sciences Announces Process Exploring Strategic Alternatives

GlobeNewswire December 6, 2023

Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

GlobeNewswire November 13, 2023

Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

GlobeNewswire November 9, 2023

Comera Life Sciences Presents SQore(TM) Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

GlobeNewswire October 16, 2023

Comera Life Sciences Announces the Completion of $4.1 Million Private Placement

GlobeNewswire September 12, 2023

Comera Life Sciences Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities

GlobeNewswire August 16, 2023

Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights

GlobeNewswire August 10, 2023

Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore(TM) Platform

GlobeNewswire August 8, 2023

Comera Life Sciences Announces $4.1 Million Private Placement

GlobeNewswire August 1, 2023

Comera Life Sciences Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore Excipients

GlobeNewswire July 20, 2023

Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights

GlobeNewswire May 11, 2023

Comera Life Sciences to Participate in Four Upcoming Conferences

GlobeNewswire April 27, 2023

Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology

GlobeNewswire April 3, 2023

Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights

GlobeNewswire March 16, 2023

Comera Life Sciences to Present at 22nd Annual PepTalk Conference

GlobeNewswire January 12, 2023

Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference

GlobeNewswire January 5, 2023

Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules

GlobeNewswire January 4, 2023

Comera Life Sciences to Participate in the Benchmark Company's Upcoming Discovery One-on-One Investor Conference

GlobeNewswire November 17, 2022

Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights

GlobeNewswire November 10, 2022